# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-014884
Filing Date
2023-08-14
Accepted
2023-08-14 16:40:20
Documents
58
Period of Report
2023-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | anvs-20230630x10q.htm iXBRL | 10-Q | 1007483
2 | EX-31.1 | anvs-20230630xex31d1.htm | EX-31.1 | 13513
3 | EX-31.2 | anvs-20230630xex31d2.htm | EX-31.2 | 13550
4 | EX-32.1 | anvs-20230630xex32d1.htm | EX-32.1 | 5707
5 | EX-32.2 | anvs-20230630xex32d2.htm | EX-32.2 | 5696
| Complete submission text file | 0001558370-23-014884.txt |  | 4939546

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | EX-101.SCH | anvs-20230630.xsd | EX-101.SCH | 30042
7 | EX-101.CAL | anvs-20230630_cal.xml | EX-101.CAL | 21845
8 | EX-101.DEF | anvs-20230630_def.xml | EX-101.DEF | 123356
9 | EX-101.LAB | anvs-20230630_lab.xml | EX-101.LAB | 250445
10 | EX-101.PRE | anvs-20230630_pre.xml | EX-101.PRE | 218820
52 | EXTRACTED XBRL INSTANCE DOCUMENT | anvs-20230630x10q_htm.xml | XML | 953932

Mailing Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312
Business Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 610-727-3913
Annovis Bio, Inc. (Filer) CIK: 0001477845 (see all company filings)

EIN.: 262540421 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39202 | Film No.: 231171304
SIC: 2834 Pharmaceutical Preparations